SUMMARY : Salmonella, shigella, alkalescens-dispar, proteus, paracolon and coliform strains were tested for the presence of a coagulase enzyme as manifested by the ability to clot plasma. The shigella and proteus strains examined gave negative results ; a high percentage of the remaining strains clotted citrated plasma but this reaction was due to metabolism of citrate and subsequent liberation of calcium ions and not to a coagulase enzyme. Results depended on the bacterial strain and on the kind and dilution of plasma used. Utilization of citrate in citrated plasma was compared with the ability of the tested strains to attack citrate in Koser's ammonium citrate medium and in sodium citrate peptone medium. The Shigella and Proteus species examined failed to utilize citrate in any of the media under the conditions of the tests, Salmonella species gave fairly uniform results in the three media, while paracolon, coliform and alkalescens-dispar strains differed in their activity, the highest percentage of positive reactions being obtained in plasma-containing media.
Bacillus subtitis and Ps. aeruginosa caused clotting of rabbit but not human plasma, while Friedlander's bacillus, Alcaligenes sp., E. coli and Aerobacter aerogenes did not clot either. Reimer (1936) used various kinds of plasma without addition of anticoagulant and compared the clotting time of plasma mixed with bacterial cultures with that of control plasma. He found no ( E . coli type I). Salmonella strains originated from the National Collection of Type Cultures, shigella and alkalescens-dispar strains were sent by Dr Ewing, U.S.A., while proteus, paracolon and coliform strains were from our own collection isolated from normal and abnormal faecal specimens and classified according to Bergey's Munual of Determinative Bacteriology (194s).
Methods. Rabbit and human plasmas were tested. Rabbit blood was collected aseptically by cardiac puncture and mixed in the proportion 9 ml.
blood with 1 ml. of 10 yo (w/v) sodium citrate (final concentration 1 yo). Human plasma was obtained from a blood bank and contained 4 vol. blood to 1 vol. of 2 yo (w/v) sodium citrate (final concentration 0.4 %). In tests with heparinized plasma 4 drops of the anticoagulant were added to 20 ml. citrated human plasma. The citrate media used included Koser's (1924) ammonium citrate solution and citrate in Bacto-peptone basal medium (Kauffmann, 1951) .
Slide coagulase tests were performed with undiluted citrated rabbit plasma. For tube coagulation experiments rabbit plasma was diluted 1/10 or 115 with normal saline; the human plasma was diluted 1/4 or 1/2 or used undiluted. In tube tests 0.5 ml. of appropriate plasma was added to 0.5 ml. of an 18 hr. culture of the required organism in Hartley's tryptic broth. The results were recorded after 24 hr. incubation at 37"; negative tubes were kept under observation for 3 days.
Each batch of plasma was tested for clotting capacity by adding 1 drop of 5 yo calcium chloride to 0.5 ml. plasma. Control slide and tube coagulase tests were included in which known coagulase-positive and coagulase-negative strains of staphylococci were used. Utilization of citrate in Koser's medium at 37" was considered to be positive when growth was evident after a third successive subculture by inoculation with a straight wire at 48 hr. intervals. Utilization of citrate in the citrate peptone medium was assessed with lead acetate indicator after incubation of the cultures in triplicate sets at 37" for 2, 7 and 14 days.
RESULTS
Clotting of citrated plasma. The slide coagulase tests were uniformly negative. Occasionally granulation slowly took place which at first glance could have been mistaken for clotting, but after some practice it became evident that late and doubtful reactions were non-specific and should be recorded as negative. 
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All shigella and proteus strains were uniform in their inability to clot citrated plasma. All the E . coli and alkalescens-dispar strains and the majority of salmonella and paracolon strains clotted citrated plasma within 24 hr. With citrated human plasma an increase in the number of positive readings was obtained with 1/2 dilution of plasma (citrate concentration 0.2 %) as compared with 1/4 dilution, but with undiluted plasma only one paracolon strain gave an additional positive reaction. Citrated rabbit plasma was clotted by most strains at 1/10 dilution (citrate concentration 0.1%) and only a few more strains clotted plasma at 115 dilution. With a few exceptions strains clotted both citrated human and rabbit plasma; under the conditions of test 1 salmonella and 10 paracolon strains gave positive readings with human plasma only, while 1 salmonella and 3 paracolon strains acted only on rabbit plasma. Thus the ability to clot citrated plasma depended on the bacterial strain and also on the dilution and kind of plasma used, the concentration of citrate being the important factor. Harper & Conway (1948) showed that clotting takes place when the concentration of citrate is less than that necessary for binding free calcium ions. The clot produced in our tests was soft, occasionally with a slight precipitate and unlike the fibrin-thread type of staphylococcal coagulum which retracts from the walls of the tube.
Additional tests were performed to find out whether a change of pH value was responsible for plasma clotting. Control plasma+sterile broth had a pH of 7.2. Clotted plasma cultures were shaken to break up the clot and the pH measured by means of a glass-electrode. Various cultures showed an increase of pH value to 7.9-8.4; no clotting occurred in control media when the pH was adjusted to 8.4.
Of 140 paracolon strains tested, 16 liquefied gelatin; of these 9 did so within 1-2 days, but the remaining 7 strains acted more slowly. Eight active gelatin-liquefying strains did not clot plasma. Tests with these strains were repeated and the tubes examined every hour, but clot formation followed by solution was not observed. 
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Citrate utilization. 20 were ParacoZobactrum coliforme type I, one was P. coliforme type 11, one was P. aerogenoides type I, one was P. intermedium type 11, and 6 were irregular citrate-negative types.
To assess the clotting time of rabbit plasma (diluted 1/10>, tests were carried out with a number of paracolon and coliform strains ( Table 3) . Only one paracolon strain produced a soft clot after 2 hr. incubation, the majority of paracolon and coliform strains gave positive reactions after 10 hr.; no additional positive results were recorded after 21 hr. In contrast to the slow action of the majority of paracolon and coliform strains, our control coagulasepositive staphylococci coagulated plasma in tube tests after 2 hr. 
DISCUSSION
False positive coagulase reactions with citrated plasma by some salmonella strains (Rita, 1945a, b) and by some paracolon and coliform strains (Harper & Conway, 1948) were shown to be due to utilization of citrate with liberation of calcium ion. Evans, Buettner & Niven (1952) observed that a similar reaction accounted for the clotting of plasma by certain streptococci. Our experiments with Gram-negative intestinal bacilli show that the majority of salmonella, paracolon, coliform and alkalescens-dispar strains which clotted human or rabbit citrated plasma did so because of citrate breakdown. On the other hand, all Shigella species and three Proteus species did not cause clotting. Lominski, Conway, Harper & Rennie (1947) Corda (1947) disagreed with this basis for differentiation because of the instability of the character. Our experiments also showed the unreliability of this criterion since results occasionally varied with the batch of plasma used. Krech (1952) described some E . coli strains which possessed an active agent in bacteria-free filtrates which was capable of coagulating plasma at room temperature but not at 87'. This, apparently, is a different reaction from that investigated in our study. The ability of Ps. aeruginosa, Ps. jhorescens, €3. szlbtilis, Chromobacterium prodigiosurn and actinomycetes to clot plasma is attributed by Fredericq (1942, 1946a, b) to a different factor, namely a secretion of coagulase at 37'. Our work supports the suggestion of Harper & Conway (1948) and of Evans et al. (1952) that, to avoid false positive coagulase reactions, tests should be performed with plasmas which contain anticoagulants other than citrate, e.g. oxalate or heparin.
